Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect

S. Hescot; M. Haissaguerre; P. Pautier; E. Kuhn; M. Schlumberger; A. Berdelou

doi:10.1016/j.ejca.2018.04.001

Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect

S. Hescot, M. Haissaguerre, P. Pautier, E. Kuhn, M. Schlumberger, A. Berdelou

Research output: Contribution to journal › Letter › peer-review

26 Citations (Scopus)

Original language	English
Pages (from-to)	57-58
Number of pages	2
Journal	European Journal of Cancer
Volume	97
DOIs	https://doi.org/10.1016/j.ejca.2018.04.001
Publication status	Published - 1 Jul 2018

Access to Document

10.1016/j.ejca.2018.04.001

Cite this

@article{ee35edbc7f3b4d4ea060efb394369085,

title = "Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect",

author = "S. Hescot and M. Haissaguerre and P. Pautier and E. Kuhn and M. Schlumberger and A. Berdelou",

year = "2018",

month = jul,

day = "1",

doi = "10.1016/j.ejca.2018.04.001",

language = "English",

volume = "97",

pages = "57--58",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Immunotherapy-induced Addison's disease

T2 - A rare, persistent and potentially lethal side-effect

AU - Hescot, S.

AU - Haissaguerre, M.

AU - Pautier, P.

AU - Kuhn, E.

AU - Schlumberger, M.

AU - Berdelou, A.

PY - 2018/7/1

Y1 - 2018/7/1

UR - http://www.scopus.com/inward/record.url?scp=85047766815&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2018.04.001

DO - 10.1016/j.ejca.2018.04.001

M3 - Letter

C2 - 29731229

AN - SCOPUS:85047766815

SN - 0959-8049

VL - 97

SP - 57

EP - 58

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect

Access to Document

Other files and links

Cite this